Cargando…
Overcoming resistance to TRAIL-induced apoptosis in solid tumor cells by simultaneously targeting death receptors, c-FLIP and IAPs
The discovery of the TRAIL protein and its death receptors DR4/5 changed the horizon of cancer research because TRAIL specifically kills cancer cells. However, the validity of TRAIL-based cancer therapies has yet to be established, as most cancer cells are TRAIL-resistant. In this report, we demonst...
Autores principales: | HUANG, YING, YANG, XIANG, XU, TIANRUI, KONG, QINGHONG, ZHANG, YAPING, SHEN, YUEHAI, WEI, YUNLIN, WANG, GUANLIN, CHANG, KWEN-JEN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902065/ https://www.ncbi.nlm.nih.gov/pubmed/27210546 http://dx.doi.org/10.3892/ijo.2016.3525 |
Ejemplares similares
-
A Novel Naphthyridine Derivative, 3u, Induces Necroptosis at Low Concentrations and Apoptosis at High Concentrations in Human Melanoma A375 Cells
por: Kong, Qinghong, et al.
Publicado: (2018) -
Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism
por: Lincoln, Frank A., et al.
Publicado: (2018) -
Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonists
por: McCann, Christopher, et al.
Publicado: (2018) -
Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)
por: Rathore, Rama, et al.
Publicado: (2017) -
NGF FLIPs TrkA onto the death TRAIL in neuroblastoma cells
por: Ruggeri, P, et al.
Publicado: (2016)